AG
KITE

Aperio Group’s Kite Pharma, Inc. KITE Stock Holding History

Aperio Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,755
Closed -$1.22M – 2289
2017
Q3 		$1.22M Buy
6,755
+476
+8% +$66.3K 0.01% 1167
2017
Q2 		$651K Buy
6,279
+1,660
+36% +$135K ﹤0.01% 1494
2017
Q1 		$363K Buy
+4,619
New +$286K ﹤0.01% 1737

Aperio Group's KITE Position: Q4 2017 in Review

Aperio Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 6,755 shares — an estimated $1.22M sold.

Aperio Group first reported a position in KITE in Q1 2017 and held it in 3 quarters. The position peaked at $1.22M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Aperio Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Aperio Group sold 6,755 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.22M.
  • Aperio Group first reported a position in Kite Pharma, Inc. in Q1 2017 and held it in 3 quarters.
  • Aperio Group's Kite Pharma, Inc. position peaked at $1.22M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Aperio Group's 13F filing for Q4 2017, filed 2 Feb 2018.